There was a thread posted on this a couple of years ago, but I wanted to see if there were any new insights about the top players in the HC biotech space. Doesn't really seem like BBs really specialize in this area, and the sector seems dominated by the boutiques/MM firms.
| +365 | Evercore Intern Seizure | 54 | 12h |
| +70 | JPM M&A is Gone??? Purely Coverage Banking??? | 31 | 11h |
| +62 | Is DCM actually underrated ? | 24 | 22h |
| +51 | How do I understand vs. just memorizing? | 8 | 2h |
| +48 | Losing my personality in Banking | 9 | 22h |
| +47 | Are all Tech / TMT groups sweaty? | 38 | 23h |
| +42 | Associate & Above IB exits | 16 | 4d |
| +33 | Incoming IB Analyst: Best Ways to Prepare? | 11 | 2h |
| +27 | Which groups are ideal for laterals? | 12 | 22h |
| +24 | Thoughts on PEI Global Partners? | 4 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
.
To add to this, most M&A is run out of the Charlotte office.
Would echo that Centerview seems to do quite well in biotech space. Been on a few very interesting gene therapy deals in the past year. Anyone who has a moment should read Spark merger proxy.